Clinical trial

Therapeutic Study of ONO-4819CD for Ulcerative Colitis

NCT00296556 · Kyoto University, Graduate School of Medicine, Other · Terminated

Key facts

NCT number NCT00296556
Title Therapeutic Study of ONO-4819CD for Ulcerative Colitis
Official title A Randomized, Placebo-Controlled Trial of ONO-4819CD for Treatment of Mild to Moderate Ulcerative Colitis.
Lead sponsor Kyoto University, Graduate School of Medicine, Other
Collaborators National Institute of Biomedical Innovation
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Ulcerative Colitis
Intervention type Drug
Interventions Rivenprost (drug)
Enrollment 7
Start date Feb 1, 2006
Primary completion Dec 1, 2007
Completion Mar 1, 2008
First posted Feb 27, 2006
Last update posted Apr 28, 2009
Countries Japan

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies